Remdesivir is an antiviral medication originally developed by Gilead Sciences. It gained significant attention as a potential treatment for COVID-19 during the early stages of the pandemic. The drug is a nucleotide analog, which works by inhibiting the action of viral RNA-dependent RNA polymerase, essential for viral replication.
